PropThink: As ACAD Rises into Pimavanserin Data, ATM Use May Continue
Thomson Reuters ONEPress Release: PropThink
agree, i sold
I know they not dilute before results, that be the last thing they would do. I wanted shares cheap to be honest and said that. I am long.
3M shares is not dilution. It's insignificant. Read 10Q and you will know that they will not use ATM before phase III results.
Sentiment: Strong Buy